AHNAK as a Prognosis Factor Suppresses the Tumor Progression in Glioma

Abstract

The AHNAK acts as a potential tumor suppressor. Our study provides a preclinical basis for developing AHNAK as a reliable clinical prognostic indicator for glioma patients, and a new biomarker for treatment response, and a potentially therapeutic target in glioma management options.